By Modesto P. Sa-onoy
The drug Ivermectin that I cited yesterday is widely available as it is approved by the World Health Organization and the US Food and Drug Agency. It is cheapest in India, well-known for its low price for medicines. India is far but online purchase is easy. With the current dollar–peso exchange rate, it can cost just about P100. So it is still cheap.
Covexit said it appears that the formulation can be attributed to Professor Thomas Borody, from Australia, “who had even the audacity to claim that COVID-19 was easier than treating the flu.”
I had mentioned Professor Borody here last year when the issue was the “fraudulent article” in Lancet, a London-based medical journal that led to the criticism of certain medicines, one of which is surprisingly a component of ZIVERDO.
According to Covexit, ZIVERDO therapy is made of three agents: Z stands for Zinc, IVER for Ivermectin and DO for Doxycycline.
“While Professor Borody did not make public the precise dosage of his therapy, the producers of ZIVERDO opted for the following: “ZIVERDO Kit Contains Zinc Acetate 50 mg, Doxycycline 100 mg & Ivermectin 12 mg Dispersible Tablets. In addition, they also recommend Vitamin D3, to make it a “quadruple therapy.”
The therapy is offered as home kits, a “first line treatment for COVID-19 positive patients.” This therapy is administered at home, thus there is no need for hospitalization.
Covexit continues to say that “ZIVERDO therapy is also very close to the i-MASK + protocol developed by Professor Paul Marik and his colleagues, where Ivermectin and Zinc play a key role. In his recent webinar, Professor Marik mentioned Doxycycline can be added to the protocol for early treatment when needed.”
“If you are in a country such as Canada, the US, France, the UK, the Netherlands, Belgium, Spain, Portugal, Italy, Sweden, Germany and many others, for sure you will not have heard about ZIVERDO, except for blogs like this one, or some posts on social media,” Covexit said.
It explained that countries such as India (where ZIVERDO is a frontline treatment) cannot afford the kind of medicine afforded to richer, “developed” countries. Neither can they afford mass hospitalizations for a disease that can be treated at home.
The Philippines can be considered like India in these terms because price does matter. If treatment can be had at a low price then God be praised!
But if you think about it, Covexit said, when cheap effective drugs are being vehemently denied by the authorities to patients suffering from a deadly disease, can we still talk about medicine? And are such rich countries, denying life-saving treatments, really developed?
It warns: “history shows that the rise and fall of nations have many explanations. With this pandemic, it looks like greed may be a pretty good one. To think one step further, could the poor response to the pandemic be an indicator of future fall of certain nations?”
As I have insinuated in several articles, this pandemic is a creation with the fall not of nations but of the entire world. But that is discussing ahead of schedule.
Here’s another report from Covexit (December 21) citing Dr. Marc Wathelet, coronavirus specialist and consultant, who came up with a “Plan to eradicate SARS-CoV-2 from Belgium and Emergency Trial proposal for Ivermectin,” published in English on LinkedIn.
He proposes a plan that “would eradicate the new coronavirus from Belgium in less than six weeks, which would be enormously beneficial at all levels” and Belgium “could resume all economic activities and schools within three weeks, masking would become unnecessary in most contexts by the sixth week.”
His plan “requires seeing the opportunity of Ivermectin facing us, and the political will to take the necessary decisions to convert this vision into reality for Belgium. It will require tremendous leadership at the very top.”
The plan is easy: Ivermectin must be made available in all pharmacies, and any regulatory red tape that would delay its rapid distribution must be circumvented. The authorities must be involved for the rapid organization of the prophylaxis trial and the treatment trial for the severe cases.
More on Ivermectin tomorrow.
